EPSILON HEALTHCARE LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.024 AUD | -.--% |
|
-.--% | -.--% |
| Jul. 08 | Epsilon Healthcare Limited Announces Termination of Xiao Cui as Company Secretary | CI |
| Jul. 04 | Epsilon Healthcare Comes Out of Voluntary Administration | MT |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 79.43 | 59.18 | 52.88 | 44.52 | 15.81 | 7.509 |
| Enterprise Value (EV) 1 | 68.39 | 53.25 | 50.04 | 42.67 | 17.92 | 9.846 |
| P/E ratio | -22 x | -6.71 x | -4.32 x | -3.54 x | -1.48 x | -0.38 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 43.1 x | 22.2 x | 11 x | 6.4 x | 2.88 x | 1.06 x |
| EV / Revenue | 37.1 x | 20 x | 10.4 x | 6.14 x | 3.26 x | 1.38 x |
| EV / EBITDA | -26.8 x | -7.06 x | -5.38 x | -4.42 x | -2.16 x | -1.58 x |
| EV / FCF | -18.1 x | -9.3 x | -9.69 x | -6.89 x | -3.06 x | -20.1 x |
| FCF Yield | -5.52% | -10.7% | -10.3% | -14.5% | -32.7% | -4.97% |
| Price to Book | 3.72 x | 2.11 x | 2.37 x | 1.76 x | 0.81 x | 0.81 x |
| Nbr of stocks (in thousands) | 116,808 | 127,268 | 139,165 | 189,457 | 222,707 | 300,354 |
| Reference price 2 | 0.6800 | 0.4650 | 0.3800 | 0.2350 | 0.0710 | 0.0250 |
| Announcement Date | 3/2/18 | 3/29/19 | 3/31/20 | 4/30/21 | 3/31/22 | 3/31/23 |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1.844 | 2.664 | 4.792 | 6.953 | 5.498 | 7.112 |
| EBITDA 1 | -2.554 | -7.54 | -9.306 | -9.656 | -8.294 | -6.251 |
| EBIT 1 | -2.557 | -7.582 | -9.381 | -10.8 | -9.168 | -7.984 |
| Operating Margin | -138.65% | -284.59% | -195.76% | -155.26% | -166.75% | -112.26% |
| Earnings before Tax (EBT) 1 | -2.559 | -8.611 | -11.7 | -10.54 | -10.11 | -13.29 |
| Net income 1 | -2.559 | -8.611 | -11.7 | -10.54 | -9.243 | -13.29 |
| Net margin | -138.75% | -323.23% | -244.22% | -151.51% | -168.11% | -186.84% |
| EPS 2 | -0.0309 | -0.0693 | -0.0880 | -0.0663 | -0.0479 | -0.0656 |
| Free Cash Flow 1 | -3.775 | -5.724 | -5.167 | -6.19 | -5.851 | -0.4893 |
| FCF margin | -204.72% | -214.86% | -107.81% | -89.03% | -106.41% | -6.88% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/2/18 | 3/29/19 | 3/31/20 | 4/30/21 | 3/31/22 | 3/31/23 |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 2.1 | 2.34 |
| Net Cash position 1 | 11 | 5.93 | 2.84 | 1.86 | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | -0.2535 x | -0.3739 x |
| Free Cash Flow 1 | -3.78 | -5.72 | -5.17 | -6.19 | -5.85 | -0.49 |
| ROE (net income / shareholders' equity) | -22.9% | -34.8% | -46.4% | -44.2% | -41.2% | -92.2% |
| ROA (Net income/ Total Assets) | -13.9% | -17.3% | -19.4% | -20.7% | -16.9% | -19.5% |
| Assets 1 | 18.37 | 49.7 | 60.44 | 50.81 | 54.7 | 67.98 |
| Book Value Per Share 2 | 0.1800 | 0.2200 | 0.1600 | 0.1300 | 0.0900 | 0.0300 |
| Cash Flow per Share 2 | 0.0900 | 0.0500 | 0.0300 | 0.0400 | 0.0100 | 0 |
| Capex 1 | 0.36 | 3.03 | 0.71 | 1.24 | 0.75 | 0.53 |
| Capex / Sales | 19.41% | 113.79% | 14.91% | 17.76% | 13.6% | 7.44% |
| Announcement Date | 3/2/18 | 3/29/19 | 3/31/20 | 4/30/21 | 3/31/22 | 3/31/23 |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 4.88M | |
| +60.25% | 841B | |
| +38.56% | 625B | |
| -4.49% | 360B | |
| +18.30% | 327B | |
| +9.64% | 300B | |
| +14.15% | 242B | |
| +3.11% | 228B | |
| +16.98% | 227B | |
| +12.87% | 174B |
- Stock Market
- Equities
- EPN Stock
- Financials Epsilon Healthcare Limited
